Gustavo Santo Selected Research

Atrial Fibrillation

1/2020	Misdosing of Non-Vitamin K Antagonist Oral Anticoagulants in Primary Care.
1/2019	Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation: Secondary Analysis of the NAVIGATE ESUS Randomized Clinical Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gustavo Santo Research Topics

Disease

6	Stroke (Strokes) 12/2022 - 12/2018
3	Ischemic Stroke 03/2021 - 12/2018
2	Atrial Fibrillation 01/2020 - 01/2019
2	Embolic Stroke 01/2019 - 12/2018
1	Cerebral Small Vessel Diseases 01/2023
1	CADASIL 01/2023
1	Renal Insufficiency (Renal Failure) 09/2021
1	Miller Fisher Syndrome (Fisher Syndrome) 07/2021
1	Premature Cardiac Complexes (Extrasystoles) 03/2021
1	Edema (Dropsy) 01/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Atrial Premature Complexes (Premature Atrial Contraction) 01/2019
1	Patent Foramen Ovale 12/2018
1	Hemorrhage 12/2018

Drug/Important Bio-Agent (IBA)

2	AnticoagulantsIBA 01/2020 - 12/2018
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 12/2018
2	RivaroxabanIBA 01/2019 - 12/2018
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Retinaldehyde (Retinal)IBA 01/2023
1	AA amyloidosisIBA 09/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 07/2021
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 03/2021
1	Phospholipases A2 (Phospholipase A2)IBA 03/2021
1	Vitamin K FDA Link 01/2020
1	Factor Xa InhibitorsIBA 12/2018

Therapy/Procedure

3	Therapeutics 01/2020 - 12/2018
1	Thrombectomy 12/2022
1	Punctures 02/2022